Knowledge IVD Development How should diagnostic assay developers analyze method comparison data when measurement scatter increases with analyte concentration?
Author avatar

Tech Team · CamelBio

Updated 1 week ago

How should diagnostic assay developers analyze method comparison data when measurement scatter increases with analyte concentration?


If you compare two diagnostic methods and see the scatter of differences grow with concentration, don't trust a standard absolute difference plot. That variability pattern—known as proportional heteroscedasticity—means every high-concentration data point weighs disproportionately in a classic Bland‑Altman analysis. The immediate fix is to switch to relative percentage difference plots or log‑transformed difference plots, then complement the visual check with weighted regression to accurately tease apart constant calibration bias from concentration‑dependent random error.

The core challenge is that increasing random error with analyte level (constant %CV) breaks the assumptions of ordinary regression and absolute‑difference plots. You restore a valid comparison by analyzing data on a relative scale and by using weighted Deming regression that gives higher mathematical weight to low‑concentration, lower‑variance measurements.

Why Standard Absolute Plots Fail at Wide Measurement Ranges

The Proportional Scatter Problem

When your assay spans a wide analytical range, imprecision rarely stays flat. Instead, the standard deviation (SD) scales proportionally with the concentration—your percent coefficient of variation (%CV) stays roughly constant. In an absolute Bland‑Altman plot, the points far to the right spread wide and dominate the visualization. They pull the average difference and limits of agreement toward themselves, hiding what’s happening in the clinically critical low‑range region.

The Unweighted Regression Trap

The same weighting issue corrupts regression. Ordinary linear models assume constant variance. Under proportional error, unweighted regression minimises large residuals at high concentrations and delivers biased slope and intercept estimates. The standard errors inflate, making you think the methods agree worse than they really do or masking a true systematic offset.

Visual Diagnostics That Stabilize Variance

Relative (Percentage) Difference Plots

Plot the percentage difference [(y2 – y1) / average] × 100% versus the average concentration. This flattens the variance across the measuring range. Now you can quickly separate two patterns:

  • Constant calibration bias shows up as a trend where most points lie off the zero line in one direction.
  • Proportional random error (%CV) appears as an even scatter band whose width stays roughly unchanged from low to high values.

Log‑Transformed Difference Plots

Taking the log of both measurements and then plotting differences (log(y2) – log(y1)) against the average of the logs achieves the same stabilising effect. Log‑transformed axes are particularly intuitive if your assay naturally generates exponentially distributed data or when you later want to back‑transform limits of agreement into symmetrical percent‑based boundaries.

Handling the Low‑End Breakdown

Near the limit of detection, the proportional‑error model often fails because the constant SD floor takes over. You can apply a mixed‑variance model: use a constant SD for the lower range (where absolute error dominates) and a constant %CV for the mid‑to‑high range. Show this breakpoint clearly on your relative difference plot, and annotate whether the low‑concentration region needs separate acceptance criteria.

Regression Analysis That Respects the Error Structure

Weighted Deming Regression as the Gold Standard

When you need to quantify systematic bias from a method comparison where both methods show variable imprecision, use weighted Deming regression. This approach assigns a weight to each data point that is inversely proportional to its squared SD (its variance). Practically, that means measurements at low concentrations—where absolute error is small—receive the highest weight and dominate the slope and intercept estimation. The result is an unbiased estimate of proportional and constant bias.

Setting the Weights Correctly

Your weight function must mirror the actual error structure. If the reference method’s CV is well‑characterised, weight by 1 / (CV × concentration)². When neither method’s precision profile is fully known, a two‑step iterative Deming procedure can first estimate variance functions, then feed them into the weighted fit. Always report the weighting scheme transparently so regulators and reviewers can retrace your logic.

Understanding the Trade‑offs

You Lose Visual Simplicity

Relative difference plots and log‑transforms make the axes less tangible for non‑statistical audiences. Percentage differences can explode as averages approach zero if you don’t cap or trim the axis. Prepare an accompanying absolute Bland‑Altman for communication, but explicitly note where it misrepresents proportional error.

Lower‑Weight Data Points Can Hide Local Issues

Weighted regression deliberately downplays high‑concentration residuals. If a new interference only appears at supratherapeutic levels, a heavily weighted model might miss it. Complement your regression with a residual‑versus‑concentration plot on the original scale and look for structured patterns in the de‑weighted region.

Model Choice Adds Complexity

Choosing between relative difference plots, log‑transforms, and mixed‑variance approaches depends on your assay’s error structure. If you assume a constant %CV and it’s actually not stable at the extremes, your weighted Deming results will be biased. Always validate the variance model with replicate precision profiles before committing.

Making the Right Choice for Your Study Design

Your specific analytical range and precision data should guide the final toolkit. Here are the most common scenarios and the recommended action:

  • If your primary focus is visual inspection across two or more decades of concentration: Use a relative percentage difference plot as your main graphic. Add a log‑transformed Bland‑Altman if you need symmetrical limits of agreement you can back‑transform to percentages.
  • If your primary focus is quantifying systematic bias for a regulatory submission: Implement weighted Deming regression with weights derived from precision profiles. Present both slope and intercept estimates with uncertainty, and explicitly state your variance function.
  • If your primary focus is assessing performance near the limit of detection: Combine a mixed‑variance model with careful breakpoint analysis. Show the low‑range segment in both absolute and relative units to prove you haven’t hidden an offset where clinical decisions hang.

Armed with a relative‑scale visual and a properly weighted regression, you’ll stop the noise at the high end from shouting over the signal where it matters most.

Summary Table:

Analytical Scenario / Focus Recommended Strategy Key Benefit
Visualizing Wide-Range Data Relative Percentage / Log-Transformed Plot Stabilizes variance across concentrations and prevents high-concentration points from skewing visual assessment.
Quantifying Systematic Bias Weighted Deming Regression Assigns higher mathematical weight to lower concentrations, preventing biased slope and intercept estimates.
Assessing Performance Near LoD Mixed-Variance Model (Break-point Analysis) Accounts for constant absolute SD at low concentrations while maintaining constant %CV at higher levels.
Evaluating Outliers / Interference Residual-versus-Concentration Plot Exposes hidden systematic patterns or interferences in lower-weighted high-concentration regions.

Accelerate Your Diagnostic Assay Development from Concept to Clinic

Navigating complex method comparisons, variance modeling, and regulatory validation requires both statistical precision and reliable assay components. CamelBio provides diagnostic manufacturers, laboratories, and research institutes with one-stop access to high-performance IVD raw materials, technical services, and expert consulting—supporting every stage of your assay lifecycle.

Whether you need robust reagents or expert technical consultation to optimize assay performance, our team is here to support your success. Contact CamelBio today to streamline your path to market.


Leave Your Message